Molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof
US7695915B2 · kind B2 · utility
1Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2008 |
| Grant date | Apr 13, 2010 |
| Priority date | — |
| Expiry date | Aug 9, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/16
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention is based on the discovery of a unique 14-gene molecular prognostic signature that is useful for predicting breast cancer metastasis. In particular, the present invention relates to methods and reagents for detecting and profiling the expression levels of these genes, and methods of using the expression level information in predicting risk of breast cancer metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.